Authors:
RING BJ
CATLOW J
LINDSAY TJ
GILLESPIE T
ROSKOS LK
CERIMELE BJ
SWANSON SP
HAMMAN MA
WRIGHTON SA
Citation: Bj. Ring et al., IDENTIFICATION OF THE HUMAN CYTOCHROMES P450 RESPONSIBLE FOR THE IN-VITRO FORMATION OF THE MAJOR OXIDATIVE METABOLITES OF THE ANTIPSYCHOTICAGENT OLANZAPINE, The Journal of pharmacology and experimental therapeutics, 276(2), 1996, pp. 658-666
Citation: Sp. Swanson et Ww. Wilhelm, PLANTING DATE AND RESIDUE RATE EFFECTS ON GROWTH, PARTITIONING, AND YIELD OF CORN, Agronomy journal, 88(2), 1996, pp. 205-210
Authors:
CATLOW JT
BARTON RD
CLEMENS M
GILLESPIE TA
GOODWIN M
SWANSON SP
Citation: Jt. Catlow et al., ANALYSIS OF OLANZAPINE IN HUMAN PLASMA UTILIZING REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION, Journal of chromatography B. Biomedical applications, 668(1), 1995, pp. 85-90
Citation: Ja. Eckstein et Sp. Swanson, DETERMINATION OF A NOVEL PHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONATE RECEPTOR ANTAGONIST (LY300164) AND ITS N-ACETYL METABOLITE IN MOUSE, RAT, DOG, AND MONKEY PLASMA USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION, Journal of chromatography B. Biomedical applications, 668(1), 1995, pp. 153-158
Citation: Bj. Jacobsen et al., OCCURRENCE OF FUNGI AND MYCOTOXINS ASSOCIATED WITH FIELD MOLD DAMAGEDSOYBEANS IN THE MIDWEST, Plant disease, 79(1), 1995, pp. 86-89
Authors:
SWANSON SP
CATLOW J
POHLAND RC
CHAY SH
JOHNSON T
Citation: Sp. Swanson et al., DISPOSITION OF THE OPIOID ANTAGONIST, LY255582, IN RATS AND DOGS, Drug metabolism and disposition, 23(9), 1995, pp. 916-921
Authors:
FOREMAN MM
FULLER RW
LEANDER JD
BENVENGA MJ
WONG DT
NELSON DL
CALLIGARO DO
SWANSON SP
LUCOT JB
FLAUGH ME
Citation: Mm. Foreman et al., PRECLINICAL STUDIES ON LY228729 - A POTENT AND SELECTIVE SEROTONIN(1A) AGONIST, The Journal of pharmacology and experimental therapeutics, 267(1), 1993, pp. 58-71